|
|
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (93.5%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (6.5%): primarily royalties.
The United States account for 66.5% of net sales.
Number of employees : 24 200 people.
|
|
|
| 2020 | 2021 | Delta | | Human Therapeutics | 24 240.00 | 95.3% | 24 297.00 | 93.5% | +0.24% |
| Other | 1 184.00 | 4.7% | 1 682.00 | 6.5% | +42.06% |
| USD in Million |
|
|
|
| 2020 | 2021 | Delta | | United States | 18 496.00 | 72.8% | 18 194.00 | 70% | -1.63% |
| Rest of the World | 6 787.00 | 26.7% | 7 672.00 | 29.5% | +13.04% |
| Canada | 141.00 | 0.6% | 113.00 | 0.4% | -19.86% |
| USD in Million |
|
|
|
| Vote  | Quantity | Free-Float | Company-owned shares | Total Float |
| Stock A |
1 |
533,579,206 |
532,474,452 |
99.8% |
0 |
0.0% |
99.8% |
|
| Shareholders | |
|
| Name | Equities | % | | Capital Research & Management Co. | 71,504,200 |
13.4% | | The Vanguard Group, Inc. | 45,190,910 |
8.47% | | SSgA Funds Management, Inc. | 29,073,061 |
5.45% | | PRIMECAP Management Co. | 15,564,870 |
2.92% | | Capital Research & Management Co. (Global Investors) | 12,605,265 |
2.36% | | NWQ Investment Management Co. LLC | 11,762,842 |
2.20% | | BlackRock Fund Advisors | 11,674,835 |
2.19% | | Geode Capital Management LLC | 11,200,793 |
2.10% | | Charles Schwab Investment Management, Inc. | 9,236,530 |
1.73% | | Smith Barney Asset Management | 8,448,585 |
1.58% |
| Name | Equities | % | | BB Gestão de Recursos DTVM SA | 333,351 |
0.0022% | | Caixa DTVM SA | 229,917 |
0.0015% | | Safra Asset Management Ltda. | 98,900 |
0.0007% | | Bram Bradesco Asset Management S/A DTVM | 59,954 |
0.0004% | | Credit Suisse Hedging-Griffo Wealth Management SA | 4 |
0.0000% |
|
|
|
| Name | Equities | % | Valuation |
| BEIGENE, LTD. (6160) |
246,269,426 |
18.2% |
4,234,410,690 USD |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION (NAMS) |
4,910,000 |
6.02% |
53,519,000 USD |
| IMAGO BIOSCIENCES, INC. |
1,193,047 |
3.53% |
42,890,040 USD |
| VIGIL NEUROSCIENCE, INC. (VIGL) |
3,206,281 |
9.01% |
40,078,513 USD |
| JASPER THERAPEUTICS, INC. (JSPR) |
2,700,000 |
7.28% |
1,304,100 USD |
|
|
|
|
- International Market - DJIA / Nasdaq 100, S&P 100, S&P 500, Stoxx Americas 100, Stoxx Global 200 |
|
| Company contact information |
|
Amgen Inc. 1 Amgen Center Drive CA 91320-1799 Thousand Oaks, California Phone : +1 805 447 1000 Fax : +1 805 447 1010 web site : https://investors.amgen.com/ |
|
|
|
Warren tells FTC she is "particularly concerned" about Amgen and Indivior deals |
Sector Other Pharmaceuticals
|
Google
Twitter
Facebook
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
